614 related articles for article (PubMed ID: 25937176)
21. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes.
Gao X; Xu Y; Xu B; Liu Y; Cai J; Liu HM; Lei S; Zhong YQ; Irwin MG; Xia Z
Diabetes Metab Res Rev; 2012 Jul; 28(5):409-17. PubMed ID: 22389139
[TBL] [Abstract][Full Text] [Related]
22. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.
Huynh K; McMullen JR; Julius TL; Tan JW; Love JE; Cemerlang N; Kiriazis H; Du XJ; Ritchie RH
Diabetes; 2010 Jun; 59(6):1512-20. PubMed ID: 20215428
[TBL] [Abstract][Full Text] [Related]
23. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.
Gimenes R; Gimenes C; Rosa CM; Xavier NP; Campos DHS; Fernandes AAH; Cezar MDM; Guirado GN; Pagan LU; Chaer ID; Fernandes DC; Laurindo FR; Cicogna AC; Okoshi MP; Okoshi K
Cardiovasc Diabetol; 2018 Jan; 17(1):15. PubMed ID: 29343259
[TBL] [Abstract][Full Text] [Related]
24. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
26. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling.
Worou ME; Belmokhtar K; Bonnet P; Vourc'h P; Machet MC; Khamis G; Eder V
Cardiovasc Res; 2011 Jul; 91(2):320-9. PubMed ID: 21406596
[TBL] [Abstract][Full Text] [Related]
27. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
[TBL] [Abstract][Full Text] [Related]
28. Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.
Parajuli N; Patel VB; Wang W; Basu R; Oudit GY
Clin Sci (Lond); 2014 Sep; 127(5):331-40. PubMed ID: 24624929
[TBL] [Abstract][Full Text] [Related]
29. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
30. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
[TBL] [Abstract][Full Text] [Related]
32. 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy.
Thandavarayan RA; Watanabe K; Ma M; Veeraveedu PT; Gurusamy N; Palaniyandi SS; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 May; 75(9):1797-806. PubMed ID: 18342293
[TBL] [Abstract][Full Text] [Related]
33. An Improvement of Oxidative Stress in Diabetic Rats by Ubiquinone-10 and Ubiquinol-10 and Bioavailability after Short- and Long-Term Coenzyme Q10 Supplementation.
Prangthip P; Kettawan A; Posuwan J; Okuno M; Okamoto T
J Diet Suppl; 2016 Nov; 13(6):647-59. PubMed ID: 27064932
[TBL] [Abstract][Full Text] [Related]
34. Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus.
Thandavarayan RA; Watanabe K; Ma M; Gurusamy N; Veeraveedu PT; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H911-9. PubMed ID: 19617408
[TBL] [Abstract][Full Text] [Related]
35. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
Lei L; Hu H; Lei Y; Feng J
Biochem Biophys Res Commun; 2018 Nov; 506(3):668-673. PubMed ID: 30454704
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
38. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
39. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
Tan SM; Zhang Y; Wang B; Tan CY; Zammit SC; Williams SJ; Krum H; Kelly DJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):650-6. PubMed ID: 22612418
[TBL] [Abstract][Full Text] [Related]
40. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
